Related Experiment Video
Updated: Jul 25, 2025

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
Published on: December 8, 2023
UAS™-A Urine Preservative for Oncology Applications
Stephanie Jordaens1,2, Amit Arora3, Kyle W MacDonald3
1Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.
Urine preservation is crucial for cancer research. UAS™ effectively preserves urinary cell-free DNA (cfDNA) and cellular integrity for up to 14 days at room temperature, preventing degradation and microbial growth.
Area of Science:
- Oncology
- Biochemistry
- Molecular Diagnostics
Background:
- Liquid biopsy offers a non-invasive approach for cancer diagnostics.
- Urine is a valuable biofluid for detecting various cancers.
- Preservation of urinary analytes is essential for accurate diagnostic testing.
Purpose of the Study:
- To evaluate UAS™ as a preservative for urinary analytes.
- To assess the impact of UAS™ on cell-free DNA (cfDNA) and host cell integrity.
- To determine the efficacy of UAS™ in clinical samples from cancer patients.
Main Methods:
- Urine samples from healthy volunteers and cancer patients were analyzed.
- UAS™ performance was tested for cfDNA and cell integrity at room temperature and after freeze-thaw cycles.
- Compatibility of UAS™ with commercial isolation kits was assessed.
Main Results:
- Unpreserved urine showed cfDNA degradation and bacterial growth at room temperature.
- UAS™ prevented microbial growth and maintained cfDNA and cellular integrity for 14 days at room temperature.
- UAS™ significantly improved preservation of cfDNA and host cell integrity after freeze-thaw cycles.
Conclusions:
- UAS™ is an effective urine preservative for maintaining analyte stability.
- UAS™ supports non-invasive cancer diagnostics by preserving urinary biomarkers.
- UAS™ is compatible with standard cfDNA isolation methods, facilitating its use in clinical settings.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
08:53Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urinary Tract Calculi III: Medical Management
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Calculi V: Nursing Management
Urine Studies I: Urinalysis